POPA ReconCME & NYSE are lobbying US regulators to increase oversight of Hyperliquid
CME & NYSE are lobbying US regulators to increase oversight of Hyperliquid Reports indicate that CME Group and Intercontinental Exchange (NYSE's parent) are pushing US regulators to tighten oversight of Hyperliquid, citing concerns about market manipulation, sanctions exposure, and counterparty risk. This is one of the clearest signs yet that the legacy derivatives establishment sees Hyperliquid as a direct threat, not a niche. CFTC has already signalled growing attention toward offshore and decentralised derivatives. Outcomes here could reshape the entire global derivatives landscape, whe…
The excerpt is quoted from a public Telegram channel, which owns its text.